Rush, Ireland

Niall M Fanning


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 32(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Niall M Fanning

Introduction

Niall M Fanning is a prominent inventor based in Rush, Ireland, who has made significant contributions to the field of pharmaceutical formulations. With an innovative mindset, he has secured one patent that showcases his expertise in advancing drug delivery systems.

Latest Patents

Fanning's notable patent is for a "Multiparticulate bisoprolol formulation." This formulation is designed for once-daily oral administration, wherein each particle comprises a core of bisoprolol or its pharmaceutically acceptable salt, enveloped in a polymeric coating. This innovative coating is critical as it ensures an initial lag in bisoprolol release in vivo of at least 4-6 hours post-administration. Following this lag, the formulation maintains therapeutic concentrations of bisoprolol for the remaining twenty-four hours. Such a formulation can be particularly beneficial for night-time dosing, thereby reducing the risk of acute cardiovascular events during the early morning high-risk period.

Career Highlights

Niall Fanning is associated with Biovail Laboratories, Inc., a company known for its commitment to enhancing pharmaceutical products through innovation. His work has not only contributed to the academic realm of pharmaceutical sciences but also to practical applications that benefit patients worldwide.

Collaborations

Throughout his career, Fanning has worked alongside talented colleagues, including Paul Stark and Catherine Mary Kelly. Their collaborative efforts contribute to creating more effective pharmaceutical solutions and advancing research in the field.

Conclusion

Niall M Fanning's innovative approach to pharmaceutical formulation, particularly with his multiparticulate bisoprolol formulation, marks a significant achievement in drug delivery systems. His work continues to influence practices within the pharmaceutical industry, highlighting the importance of innovation in improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…